Back to Search
SABINA SIGNORETTI, M.D.
M.D.
Molecular Genetic Pathology (Pathology) Physician
NPI: 1629510995IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Molecular Genetic Pathology (Pathology) PhysicianPrimary
Pathology — Molecular Genetic Pathology
Code: 207ZP0007X
272890(MA)
CMS Specialties
PrimaryPATHOLOGY
Education
OTHER
Class of 1988
Research & Publications (20)
Carbonic anhydrase IX as a predictive biomarker of response to kidney cancer therapy.
PMID 18430120·BJU Int·2008
6-review
Tissue-based research in kidney cancer: current challenges and future directions.
PMID 18559586·Clin Cancer Res·2008
6-review
p63 regulates commitment to the prostate cell lineage.
PMID 16051706·Proc Natl Acad Sci U S A·2005
4-observational
Estrogen receptor beta in prostate cancer: brake pedal or accelerator?
PMID 11438447·Am J Pathol·2001
6-review
Her-2-neu expression and progression toward androgen independence in human prostate cancer.
PMID 11106683·J Natl Cancer Inst·2000
8-other
p63 is a prostate basal cell marker and is required for prostate development.
PMID 11106548·Am J Pathol·2000
7-preclinical
Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.
PMID 19470766·Cancer Res·2009
4-observational
Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model?
PMID 19474376·Radiology·2009
7-preclinical
Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference.
PMID 19402064·Cancer·2009
8-other
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.
PMID 19318631·J Natl Cancer Inst·2009
7-preclinical
Treatment selection for patients with metastatic renal cell carcinoma.
PMID 19402069·Cancer·2009
6-review
LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer.
PMID 19276158·Mol Cancer Ther·2009
7-preclinical
A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression.
PMID 18691549·Cancer Cell·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 75 FRANCIS ST
BOSTON, MA 02115 - Phone
- (617) 525-7437
Quick Facts
- NPI
- 1629510995
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile